GSK Scores a First: FDA Approves Lynavoy for Chron...
Category : Approval/Launch 23 March 2026Some conditions are overlooked—not because they’re rare, but because they’re misun...
Approval Launch
European Commission Approves Lupin’s Biosimilar Ra...
Category : Approval/Launch 24 February 2026Lupin Limited has received approval from the European Commission for its biosimilar ranibizumab, Ran...
FDA Accepts Dr Reddy’s 351(k) BLA for Proposed Int...
Category : Approval/Launch 24 February 2026Dr. Reddy's Laboratories has announced that the U.S. Food and Drug Administration (FDA) has acce...
Zydus introduces biosimilar Aflibercept 2 mg Anyra...
Category : Approval/Launch 20 February 2026Zydus Lifesciences Ltd., an innovation-led global life sciences company, announced the launch of Any...
Takeda’s Oveporexton Receives FDA Priority Review...
Category : Approval/Launch 12 February 2026Takeda announced that the US FDA has accepted its New Drug Application (NDA) for oveporexton (TAK-86...
Latest Newsletter Post
-
GSK’s Bepirovirsen Moves Closer to..
30 March 2026
-
AstraZeneca’s Tozorakimab Shows Str..
30 March 2026
-
Bavarian Nordic Moves to Expand Mpo..
30 March 2026
-
Can You Re-Vaccinate for RSV Effect..
27 March 2026
-
Reinventing a 90-Year-Old TB Test:..
27 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com